Skip to content

Cranberry Juice in the Prevention of Urinary Tract Infections in Children

The Efficacy of Cranberry Juice in the Prevention of Urinary Tract Infections in Children - Randomized, Placebo Controlled Multi-Center Study

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00638170
Enrollment
262
Registered
2008-03-18
Start date
2001-05-31
Completion date
2009-02-28
Last updated
2009-02-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Urinary Tract Infections

Keywords

Urinary Tract Infections, Cranberry, Prevention

Brief summary

The objective of the study is to determine whether recurrences of urinary tract infection in children can be prevented with cranberry juice.

Detailed description

Five percent of children have at least one UTI episode and 30% of these episodes recur. Recurrences and the risk of renal damage are indications for long term antimicrobial prophylaxis, but emerging antimicrobial resistance underlines the need for alternatives. The bacteria causing urinary tract infection arise from the stools. Dietary changes can alter the balance of faecal bacteria. Vaccinium berries and products containing lactobacilli have been shown to act against the coliform bacteria that cause most urinary tract infections. In our previous study cranberry juice was effective in preventing symptomatic recurrences of urinary tract infections in women. The objective of our study is to determine whether recurrences of urinary tract infection in children can be prevented with cranberry juice.

Interventions

BIOLOGICALCranberry juice

5 ml/kg up to 300 ml, 1-2 doses daily for six months

BIOLOGICALPlacebo juice

5 ml/kg up to 300 ml, 1-2 doses daily for six months

Sponsors

Ocean Spray, Inc.
CollaboratorINDUSTRY
University of Oulu
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
QUADRUPLE (Subject, Caregiver, Investigator, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
1 Years to 16 Years
Healthy volunteers
No

Inclusion criteria

* Urinary Tract Infection 0-2 months priorly

Exclusion criteria

* Antibiotic Prophylaxis

Design outcomes

Primary

MeasureTime frame
Occurrence of the first recurrence12 months

Secondary

MeasureTime frame
Total number of UTI episodes and use of antimicrobials12 months

Countries

Finland

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026